Australia Últimas notícias

Sarvam AI has become India's latest AI unicorn after raising $234M from investors including HCL Tech, Bessemer, and Khosla Ventures. Co-founder, Pratyush Kumar, joined Paul Allen on Insight with Haslinda Amin t

Aerometrex (ASX:AMX) signed two off‑the‑shelf data licence agreements with AI companies Zeromatter Technologies and Neara, with a combined value of A$1.07 million.

Cynata Therapeutics (ASX:CYP) reported primary evaluation results from its Phase 2 trial of CYP‑001 in high‑risk acute graft versus host disease, showing no significant difference in response rates compared with the control group.

Despite Zhipu being the hottest stock on the HSTECH Index this year, Felix Wang of Hedgeye Risk Management says the fair value for the stock on the short side is HK$407. He adds that Zhipu lacks pricing power, particularly after the release of DeepSeek's V4 model, which has triggered a price war among Chinese AI firms. He spoke on "Bloomberg: The China Show."

Iran is set to receive broad financial incentives as part of its agreement with the US, including the right to sell oil immediately, according to a final draft of the deal. Bloomberg's Abeer Abu Omar reports from Dubai.

Australian trade unions announced on June 17 an agreement to end strike action at the onshore and offshore Ichthys LNG facilities.

Resources & Energy Group (ASX:REZ) signed a gold mining agreement with Rembrandt Mining.

Aisa Ogoshi of JPMorgan Asset Management says "risk obviously is in the tech trade" due to the market concentration. But she adds that "there's more upside to the tech trade" in terms of the AI data center supply chain. Ogoshi also discusses the outlook for the Bank of Japan.

Norwood Systems (ASX:NOR) executed an agreement for a $285,000 paid platform pilot with a major United Kingdom telecommunications provider.

Aerometrex (ASX:AMX) has secured two off-the-shelf data licence agreements with AI companies worth a combined $1.1 million.

Northern Minerals (ASX:NTU) has secured a three-month extension to delay its annual general meeting until Sept. 30.

Neurizon Therapeutics (ASX:NUZ) executed an agreement with Elanco Animal Health (NYSE:ELAN) to secure a five-year supply of human-health monepantel.